June 2024
1. CHITTORA R, Jain S, Roy A, Pandey S, et al
   Multifactorial effects of short duration early exposure low intensity magnetic field stimulation in Streptozotocin induced Alzheimer's disease rat model.
   Neurosci Lett. 2024;836:137878.
   

   >> Share

   
   
2. SMITH AS, Subramanian J, Doderer J, Moskovitz J, et al
   Methionine oxidation of clusterin in Alzheimer's disease and its effect on clusterin's binding to beta-amyloid.
   Neurosci Lett. 2024;836:137874.
   

   >> Share

   
   May 2024
3. TU Y, Xu B
   Esketamine induces tripartite motif-containing protein 24 to improve cognitive dysfunction in Alzheimer's disease.
   Neurosci Lett. 2024 May 25:137836. doi: 10.1016/j.neulet.2024.137836.
   

   >> Share

   
   
4. YANG C, Wu X, Feng J, Wu C, et al
   Clinical values of serum C5a in Alzheimer's disease patients with different dementia stages.
   Neurosci Lett. 2024 May 23:137833. doi: 10.1016/j.neulet.2024.137833.
   

   >> Share

   
   
5. FAZELINEJAD H, Zahedi E, Khadivi M
   Altering plasma lipids and liver enzyme activities via hippocampal injections of hen Lysozyme amyloid aggregates in an Alzheimer's disease mouse model: Insights into the therapeutic role of Bis (Indolyl) phenylmethane.
   Neurosci Lett. 2024;833:137825.
   

   >> Share

   
   
6. CHEN W, Zhang T, Zhang H
   Genes related to neurotransmitter receptors as potential biomarkers for Alzheimer's disease.
   Neurosci Lett. 2024;832:137816.
   

   >> Share

   
   
7. AAMERI R, Ghorbani H, Reza Bazrafshan H, Zahra Gharib F, et al
   Retraction notice to "Iranian thyme honey plays behavioral, cellular and molecular important roles as an amazing preventive and therapeutic agent in the brain of Alzheimer's rat model" [Neurosci. Lett. 783 (2022) 136702].
   Neurosci Lett. 2024 May 4:137793. doi: 10.1016/j.neulet.2024.137793.
   

   >> Share

   
   April 2024
8. XIANG X, Xia S, Li S, Zeng Y, et al
   Study on the role and mechanism of Tan IIA in Alzheimer's disease based on CREB-BDNF-TrkB pathway.
   Neurosci Lett. 2024;830:137769.
   

   >> Share

   
   
9. ZHANG Y, Wu F
   Diagnostic value and cognitive regulatory roles of long non-coding RNA UCA1 in Alzheimer's disease.
   Neurosci Lett. 2024 Apr 5:137765. doi: 10.1016/j.neulet.2024.137765.
   

   >> Share

   
   March 2024
10. CHEN J, Su C, Ma Z, Ou X, et al
    Aerobic exercise suppresses cognitive injury in patients with Alzheimer's disease by regulating long non-coding RNA TUG1.
    Neurosci Lett. 2024;826:137732.
    

    >> Share

    
    
11. FENG Q, Li X, Liu R, Liu G, et al
    Overexpression of MTMR14 induced learning and memory impairments in 2-month-old C57 mice.
    Neurosci Lett. 2024;825:137700.
    

    >> Share

    
    February 2024
12. SHIGEMATSU K, Komori N, Ideno M, Yamagishi H, et al
    "Evaluation of neprilysin activity in Adipose-Derived stem cells from Alzheimer's disease patients".
    Neurosci Lett. 2024;825:137705.
    

    >> Share

    
    
13. HUANG W, Chen Q, Zhou P, Ye S, et al
    Neuroprotective effect of chrysophanol in Alzheimer disease via modulating the Ca(2+)/EGFR-PLCgamma pathway.
    Neurosci Lett. 2024 Feb 12:137684. doi: 10.1016/j.neulet.2024.137684.
    

    >> Share

    
    
14. CAKIR M, Sacmaci H
    The relationship of salusins with Parkinson's Disease, Alzheimer's Disease, and acute ischemic stroke: A preliminary study.
    Neurosci Lett. 2024 Feb 11:137683. doi: 10.1016/j.neulet.2024.137683.
    

    >> Share

    
    
15. KAAR A, Weir MP, Rae MG
    Altered neuronal group 1 metabotropic glutamate receptor- and endoplasmic reticulum-mediated Ca(2+) signaling in two rodent models of Alzheimer's disease.
    Neurosci Lett. 2024;823:137664.
    

    >> Share

    
    January 2024
16. XIE YH, Jiang L, Zhang Y, Deng YH, et al
    Antagonizing LINGO-1 reduces activated microglia and alleviates dendritic spine loss in the hippocampus of APP/PS1 transgenic mice.
    Neurosci Lett. 2024;820:137612.
    

    >> Share

    
    
17. ROBBIE L, Fernandez SG, Montoya L, Sagare A, et al
    Age of onset predicted by Abeta profiling in a novel PSEN1 (I180F) mutation.
    Neurosci Lett. 2024;820:137591.
    

    >> Share

    
    
18. CHEN TJ, Hung HS, Cheng TL, Wang DC, et al
    Histone deacetylase inhibitor attenuates the effects of 27-hydroxycholesterol on the rat brain.
    Neurosci Lett. 2024;818:137533.
    

    >> Share

    
    December 2023
19. ZHANG Y, Shen S, Li X, Wang S, et al
    A multiclass extreme gradient boosting model for evaluation of transcriptomic biomarkers in Alzheimer's disease prediction.
    Neurosci Lett. 2023;821:137609.
    

    >> Share

    
    November 2023
20. LIU L, Liu L, Lu Y, Zhang T, et al
    GDP dissociation inhibitor 1 (GDI1) attenuates beta-amyloid-induced neurotoxicity in Alzheimer's diseases.
    Neurosci Lett. 2023;818:137564.
    

    >> Share

    
    
21. ZARIFKAR AH, Zarifkar A, Safaei S
    Different paradigms of transcranial electrical stimulation induce structural changes in the CA1 region of the hippocampus in a rat model of Alzheimer's disease.
    Neurosci Lett. 2023 Nov 22:137570. doi: 10.1016/j.neulet.2023.137570.
    

    >> Share

    
    
22. GUO F, Kang J, Xu J, Wei S, et al
    Genome-wide identification of m(6)A-associated single nucleotide polymorphisms in complex diseases of nervous system.
    Neurosci Lett. 2023;817:137513.
    

    >> Share

    
    
23. ZHANG J, Guo S, Tao R, Wang F, et al
    Neuroprotective effect of plasmalogens on AlCl(3)-induced Alzheimer's disease zebrafish via acting on the regulatory network of ferroptosis, apoptosis and synaptic neurotransmission release with oxidative stress as the center.
    Neurosci Lett. 2023;818:137560.
    

    >> Share

    
    October 2023
24. GHOLAMI A
    Alzheimer's disease: The role of proteins in formation, mechanisms, and new therapeutic approaches.
    Neurosci Lett. 2023;817:137532.
    

    >> Share

    
    
25. KISHORE N, Goel N
    Deep learning based diagnosis of Alzheimer's disease using FDG-PET images.
    Neurosci Lett. 2023 Oct 17:137530. doi: 10.1016/j.neulet.2023.137530.
    

    >> Share

    
    September 2023
26. KAMRANFAR F, Jaktaji RP, Shirani K, Jamshidi A, et al
    Protective effect of a standardized Allium jesdianum extract in an Alzheimer's disease induced rat model.
    Neurosci Lett. 2023 Sep 19:137491. doi: 10.1016/j.neulet.2023.137491.
    

    >> Share

    
    August 2023
27. KARIMI-ZANDI L, Ghorbandaiepour T, Zahmatkesh M
    The increment of annexin V-positive microvesicles versus annexin V-negative microvesicles in CSF of an animal model of Alzheimer's disease.
    Neurosci Lett. 2023;814:137446.
    

    >> Share

    
    
28. BUDHBHATTI U, Joshi C, Chauhan A, Bhatt D, et al
    Association of NOTCH4 and ACHE gene polymorphism in Alzheimer's disease of Gujarat cohort.
    Neurosci Lett. 2023 Aug 4:137428. doi: 10.1016/j.neulet.2023.137428.
    

    >> Share

    
    July 2023
29. KUO YY, Chen WT, Lin GB, Chen YM, et al
    Thermal cycling-hyperthermia ameliorates Abeta(25-35)-induced cognitive impairment in C57BL/6 mice.
    Neurosci Lett. 2023;810:137337.
    

    >> Share

    
    
30. ABOLHASANI F, Pourshojaei Y, Mohammadi F, Esmaeilpour K, et al
    Exploring the potential of a novel phenoxyethyl piperidine derivative with cholinesterase inhibitory properties as a treatment for dementia: Insights from STZ animal model of dementia.
    Neurosci Lett. 2023;810:137332.
    

    >> Share

    
    
31. SHAJI S, Palanisamy R, Swaminathan R
    Structural irregularities in MR corpus callosal images and their association with cerebrospinal fluid biomarkers in Mild Cognitive Impairments.
    Neurosci Lett. 2023;810:137329.
    

    >> Share

    
    June 2023
32. NAKANISHI K, Norimatsu K, Tani A, Matsuoka T, et al
    Effects of early exercise intervention and exercise cessation on neuronal loss and neuroinflammation in a senescence-accelerated mouse prone 8.
    Neurosci Lett. 2023;808:137297.
    

    >> Share

    
    
33. CHEN L, Wang L, Zhou GF, Liu Y, et al
    TNIP2 inhibits amyloidogenesis by regulating the 3'UTR of BACE1: An in vitro study.
    Neurosci Lett. 2023;808:137265.
    

    >> Share

    
    
34. WANG M, Zhao H, Zhang Z, Zhao Z, et al
    Down-regulating insulin-like growth factor-1 receptor reduces amyloid-beta deposition in mice cortex induced by chronic sleep restriction.
    Neurosci Lett. 2023;808:137189.
    

    >> Share

    
    
35. HAMSAFAR Y, Chen Q, Borowsky AD, Beach TG, et al
    Biochemical analyses of tau and other neuronal markers in the submandibular gland and frontal cortex across stages of Alzheimer's disease.
    Neurosci Lett. 2023 Jun 15:137330. doi: 10.1016/j.neulet.2023.137330.
    

    >> Share

    
    
36. DELVENNE JF, Scally B, Rose Burke M
    Splenium tract projections of the corpus callosum to the parietal cortex classifies Alzheimer's disease and mild cognitive impairment.
    Neurosci Lett. 2023;810:137331.
    

    >> Share

    
    April 2023
37. DONG L, Chang Q, Ma J, Liu C, et al
    Associations of blood UCH-L1 and NfL levels with cognitive dysfunction in Parkinson's disease patients.
    Neurosci Lett. 2023;804:137219.
    

    >> Share

    
    
38. RODRIGUEZ JJ, Terzieva S, Yeh CY, Gardenal E, et al
    Neuroanatomical and morphometric study of S100beta positive astrocytes in the entorhinal cortex during ageing in the 3xTg-Alzehimer's disease mouse model.
    Neurosci Lett. 2023;802:137167.
    

    >> Share

    
    
39. CAI Y, Fu P, Zhang X
    Association of plasma phosphor-tau181 with Abeta levels may vary by APOE epsilon4 status and sex among non-demented old adults.
    Neurosci Lett. 2023;802:137161.
    

    >> Share

    
    
40. SOMERA B, Frick M, Fadel JR
    Age-related changes in basal forebrain afferent activation in response to food paired stimuli.
    Neurosci Lett. 2023;802:137155.
    

    >> Share

    
    March 2023
41. XIONG L, Wang Z
    BMP9 ameliorates amyloid pathology by promoting low-density lipoprotein receptor-related protein 1 expression in APP/PS1 transgenic mice.
    Neurosci Lett. 2023;801:137159.
    

    >> Share

    
    
42. WANG P, Wang X, Qiao K, Zhang Y, et al
    Reduced SUMOylation of Nrf2 signaling contributes to its inhibition induced by amyloid-beta.
    Neurosci Lett. 2023;799:137118.
    

    >> Share

    
    
43. SINGH L, Singh S
    Neuroprotective potential of Honokiol in ICV-STZ induced neuroinflammation, Abeta ((1-42)) and NF-kB expression in experimental model of rats.
    Neurosci Lett. 2023;799:137090.
    

    >> Share

    
    
44. LI H, Zhang D, Wang X, Wang S, et al
    Protective effect of glutamic-oxaloacetic transaminase on hippocampal neurons in Alzheimer's disease using model mice.
    Neurosci Lett. 2023;803:137194.
    

    >> Share

    
    
45. WEI R, He JQ, Chen WH, Tam KY, et al
    Evaluations of the neuroprotective effects of a dual-target isoquinoline inhibitor in the triple transgenic mouse model of Alzheimer's disease.
    Neurosci Lett. 2023 Mar 6:137166. doi: 10.1016/j.neulet.2023.137166.
    

    >> Share

    
    February 2023
46. ZHANG J, Zhao Y, Zhang Y, Gao Y, et al
    Alpha lipoic acid treatment in late middle age improves cognitive function: Proteomic analysis of the protective mechanisms in the hippocampus.
    Neurosci Lett. 2023;798:137098.
    

    >> Share

    
    
47. PEREZ-GARCIA G, Bicak M, Haure-Mirande JV, Perez GM, et al
    BCI-838, an orally active mGluR2/3 receptor antagonist pro-drug, rescues learning behavior deficits in the PS19 MAPT(P301S) mouse model of tauopathy.
    Neurosci Lett. 2023;797:137080.
    

    >> Share

    
    
48. WANG S, Ke S, Liu S, Wang E, et al
    APOE epsilon4 status and plasma p-tau181 interact to influence cognitive performance among non-demented older adults.
    Neurosci Lett. 2023;796:137052.
    

    >> Share

    
    January 2023
49. KUMAR A, Verma A, Chaurasia RN
    Vitamin D and inflammatory cytokines association in mild cognitive impaired subjects.
    Neurosci Lett. 2023;795:137044.
    

    >> Share

    
    
50. RAMIREZ-HERNANDEZ E, Sanchez-Maldonado C, Patricio-Martinez A, Limon ID, et al
    Amyloid-beta (25-35) induces the morphological alteration of dendritic spines and decreases NR2B and PSD-95 expression in the hippocampus.
    Neurosci Lett. 2023;795:137030.
    

    >> Share

    
    
51. DAS S, Datta S, Ghosal A, Chaudhuri NR, et al
    Screening of BACE1 inhibitors with antiamyloidogenic activity: A study of flavonoids and flavonoid derivatives.
    Neurosci Lett. 2023;792:136965.
    

    >> Share

    
    November 2022
52. XIA S, Zhang Y, Peng B, Hu X, et al
    Detection of mild cognitive impairment in type 2 diabetes mellitus based on machine learning using privileged information.
    Neurosci Lett. 2022;791:136908.
    

    >> Share

    
    
53. FARHANGIAN M, Azarafrouz F, Chavoshinezhad S, Dargahi L, et al
    Intranasal interferon-beta alleviates anxiety and depressive-like behaviors by modulating microglia polarization in an Alzheimer's disease model.
    Neurosci Lett. 2022 Nov 14:136968. doi: 10.1016/j.neulet.2022.136968.
    

    >> Share

    
    
54. FOLORUNSO OO, Harvey TL, Brown SE, Chelini G, et al
    The D-serine biosynthetic enzyme serine racemase is expressed by reactive astrocytes in the amygdala of human and a mouse model of Alzheimer's disease.
    Neurosci Lett. 2022;792:136958.
    

    >> Share

    
    October 2022
55. SHEN Q, Patten KT, Valenzuela A, Lein PJ, et al
    Probing changes in brain esterified oxylipin concentrations during the early stages of pathogenesis in Alzheimer's Disease transgenic rats.
    Neurosci Lett. 2022 Oct 18:136921. doi: 10.1016/j.neulet.2022.136921.
    

    >> Share

    
    
56. RAFIEY M, Nosrati R, Babaei P
    Protective effect of miR-34c antagomir against STZ-induced memory impairment by targeting mTOR and PSD-95 in the hippocampus of rats.
    Neurosci Lett. 2022;789:136881.
    

    >> Share

    
    September 2022
57. WANG Y, Lv S, Zhou X, Niu X, et al
    Identification of hsa-miR-365b-5p's role in Alzheimer's disease: A combined analysis of miRNA and mRNA microarrays.
    Neurosci Lett. 2022;790:136892.
    

    >> Share

    
    
58. LANG W, Li X, Wang Y, Duan Y, et al
    Sodium propionate improves cognitive and memory function in mouse models of Alzheimer's disease.
    Neurosci Lett. 2022 Sep 26:136887. doi: 10.1016/j.neulet.2022.136887.
    

    >> Share

    
    
59. TONDELLI M, Salemme S, Vinceti G, Bedin R, et al
    Predictive value of phospho-tau/total-tau ratio in amyloid-negative Mild Cognitive Impairment.
    Neurosci Lett. 2022;787:136811.
    

    >> Share

    
    August 2022
60. LONG Y, Cheng Y, Yang J, Yang T, et al
    Abeta-induced presynaptic release of UBC9 through extracellular vesicles involves SNAP23.
    Neurosci Lett. 2022;785:136771.
    

    >> Share

    
    July 2022
61. RONG Y, Mi X, Ni C, Liu T, et al
    Protective effect of vitamin C on DNA damage in surgery-induced cognitive dysfunction in APP/PS1 mice.
    Neurosci Lett. 2022;784:136740.
    

    >> Share

    
    
62. LIN J, Niu Z, Xue Y, Gao J, et al
    Chronic vitamin D3 supplementation alleviates cognition impairment via inhibition of oxidative stress regulated by PI3K/AKT/Nrf2 in APP/PS1 transgenic mice.
    Neurosci Lett. 2022;783:136725.
    

    >> Share

    
    
63. KOCA S, Kiris I, Sahin S, Cinar N, et al
    Decreased levels of cytokines implicate altered immune response in plasma of moderate-stage Alzheimer's disease patients.
    Neurosci Lett. 2022 Jul 13:136799. doi: 10.1016/j.neulet.2022.136799.
    

    >> Share

    
    
64. ZHANG Y, Liu D, Yao X, Wen J, et al
    DMTHB ameliorates memory impairment in Alzheimer's disease mice through regulation of neuroinflammation.
    Neurosci Lett. 2022 Jul 7:136770. doi: 10.1016/j.neulet.2022.136770.
    

    >> Share

    
    June 2022
65. WANG J, Wen C, Li J, Chen J, et al
    Automated quantification of brain connectivity in Alzheimer's disease using ClusterMetric.
    Neurosci Lett. 2022 Jun 10:136724. doi: 10.1016/j.neulet.2022.136724.
    

    >> Share

    
    
66. MA X, Liu L, Meng J
    Retraction notice to "MicroRNA-125b promotes neurons cell apoptosis and tau phosphorylation in Alzheimer's disease" [Neurosci. Lett. 661 (2017) 57-62].
    Neurosci Lett. 2022;783:136703.
    

    >> Share

    
    
67. AAMERI R, Ghorbani H, Reza Bazrafshan H, Zahra Gharib F, et al
    Iranian thyme honey plays behavioral, cellular and molecular important roles as an amazing preventive and therapeutic agent in the brain of Alzheimer's rat model.
    Neurosci Lett. 2022;783:136702.
    

    >> Share

    
    May 2022
68. HU Y, Wen C, Cao G, Wang J, et al
    Brain network connectivity feature extraction using deep Learning for Alzheimer's disease classification.
    Neurosci Lett. 2022 May 2:136673. doi: 10.1016/j.neulet.2022.136673.
    

    >> Share

    
    April 2022
69. WANG Y, Yang Y, Liu Y, Guo A, et al
    Cognitive impairments in type 1 diabetes mellitus model mice are associated with synaptic protein disorders.
    Neurosci Lett. 2022;777:136587.
    

    >> Share

    
    February 2022
70. PIJEWSKI RS, Sutter PA, Duszak VA, Singh N, et al
    Distinct profiles of cellular senescence-associated gene expression in the aged, diseased or injured central nervous system.
    Neurosci Lett. 2022;772:136480.
    

    >> Share

    
    
71. LI Y, Han X, Fan H, Sun J, et al
    Circular RNA AXL increases neuron injury and inflammation through targeting microRNA-328 mediated BACE1 in Alzheimer's disease.
    Neurosci Lett. 2022 Feb 12:136531. doi: 10.1016/j.neulet.2022.136531.
    

    >> Share

    
    
72. AN Y, Qi Y, Li Y, Li Z, et al
    Activation of the sigma-1 receptor attenuates blood-brain barrier disruption by inhibiting amyloid deposition in Alzheimer's disease mice.
    Neurosci Lett. 2022 Feb 11:136528. doi: 10.1016/j.neulet.2022.136528.
    

    >> Share

    
    January 2022
73. IMA X, Liu L, Meng J
    Expression of concern: MicroRNA-125b promotes neurons cell apoptosis and tau phosphorylation in Alzheimer's disease.
    Neurosci Lett. 2022;769:136229.
    

    >> Share

    
    
74. CHENFEI Z, Haizhen Y, Jie X, Na Z, et al
    Effects of aerobic exercise on hippocampal SUMOylation in APP/PS1 transgenic mice.
    Neurosci Lett. 2022;767:136303.
    

    >> Share

    
    
75. QIAN C, Zhang M
    RTN3 - ASC interaction: The potential mechanism behind diabetes-induced cortical neuritic dystrophy.
    Neurosci Lett. 2022;766:136333.
    

    >> Share

    
    December 2021
76. XUE YY, Chen YH, Lin RR, Huang HF, et al
    Alzheimer's disease susceptibility locus in CD2AP is associated with increased cerebrospinal fluid tau levels in mild cognitive impairment.
    Neurosci Lett. 2021 Dec 24:136419. doi: 10.1016/j.neulet.2021.136419.
    

    >> Share

    
    
77. WANG M, Ren Q, Shi Y, Shu H, et al
    The Effect of Alzheimer's Disease Risk Factors on Brain Aging in normal Chineses: Cognitive Aging and Cognitive Reserve.
    Neurosci Lett. 2021 Dec 16:136398. doi: 10.1016/j.neulet.2021.136398.
    

    >> Share

    
    
78. LAI X, Hu J, Liu H, Lan L, et al
    A short peptide from sAPPalpha binding to BACE1-APP action site rescues Alzheimer-like pathology.
    Neurosci Lett. 2021 Dec 13:136397. doi: 10.1016/j.neulet.2021.136397.
    

    >> Share

    
    November 2021
79. GEORGE B, D Gokhale S, Yaswanth PM, Vijayan A, et al
    Identification of Alzheimer associated differentially expressed gene through microarray data and transfer learning-based image analysis.
    Neurosci Lett. 2021;766:136357.
    

    >> Share

    
    
80. ZHOU X, Wang Y, Lv S, Li Y, et al
    Transcranial magnetic stimulation for sleep disorders in Alzheimer's disease: A double-blind, randomized, and sham-controlled pilot study.
    Neurosci Lett. 2021;766:136337.
    

    >> Share

    
    
81. ZHANG Y, Zhao Y, Zhang J, Gao Y, et al
    Ginkgolide B inhibits NLRP3 inflammasome activation and promotes microglial M2 polarization in Abeta1-42-induced microglia cells.
    Neurosci Lett. 2021;764:136206.
    

    >> Share

    
    October 2021
82. ZHU Z, Liu Y, Li X, Zhang L, et al
    GPNMB mitigates Alzheimer's disease and enhances autophagy via suppressing the mTOR signal.
    Neurosci Lett. 2021 Oct 22:136300. doi: 10.1016/j.neulet.2021.136300.
    

    >> Share

    
    
83. BANG S, Kuen Song J, Shin SW, Hee Lee K, et al
    Human Serum Albumin Fusion Protein as Therapeutics for Targeting Amyloid Beta in Alzheimer's Diseases.
    Neurosci Lett. 2021 Oct 18:136298. doi: 10.1016/j.neulet.2021.136298.
    

    >> Share

    
    September 2021
84. CASTILLO-MARIQUEO L, Gimenez-Llort L
    Kyphosis and bizarre patterns impair spontaneous gait performance in end-of-life mice with Alzheimer's disease pathology while gait is preserved in normal aging.
    Neurosci Lett. 2021 Sep 30:136280. doi: 10.1016/j.neulet.2021.136280.
    

    >> Share

    
    
85. GAO F, Liu T, Tuo M, Chi S, et al
    The role of orexin in Alzheimer disease: From sleep-wake disturbance to therapeutic target.
    Neurosci Lett. 2021;765:136247.
    

    >> Share

    
    
86. LU X, Zhang Y, Li H, Jin Y, et al
    Nicotine prevents in vivo Abeta toxicity in Caenorhabditis elegans via SKN-1.
    Neurosci Lett. 2021;761:136114.
    

    >> Share

    
    
87. KURIMOTO E, Yamada R, Hirakawa T, Kimura H, et al
    Therapeutic Potential of TAK-071, a Muscarinic M1 Receptor Positive Allosteric Modulator with Low Cooperativity, For the Treatment of Cognitive Deficits and Negative Symptoms Associated with Schizophrenia.
    Neurosci Lett. 2021 Sep 9:136240. doi: 10.1016/j.neulet.2021.136240.
    

    >> Share

    
    
88. RADAGHDAM S, Karamad V, Nourazarian A, Shademan B, et al
    Molecular mechanisms of sex hormones in the development and progression of Alzheimer's disease.
    Neurosci Lett. 2021 Sep 6:136221. doi: 10.1016/j.neulet.2021.136221.
    

    >> Share

    
    August 2021
89. RIZZI L, Balthazar MLF
    Mini-review: The suspected non-Alzheimer's disease pathophysiology.
    Neurosci Lett. 2021 Aug 31:136208. doi: 10.1016/j.neulet.2021.136208.
    

    >> Share

    
    
90. KIM TA, Chen L, Ge S
    The interplay of neurovasculature and adult hippocampal neurogenesis.
    Neurosci Lett. 2021;760:136071.
    

    >> Share

    
    
91. WEI X, Xie L, Du P, Zhao Z, et al
    Impacts of DNA methylation on Tau protein related genes in the brains of patients with Alzheimer's Disease.
    Neurosci Lett. 2021 Aug 23:136196. doi: 10.1016/j.neulet.2021.136196.
    

    >> Share

    
    
92. ZHAO N, Xu B
    The beneficial effect of exercise against Alzheimer's disease may result from improved brain glucose metabolism.
    Neurosci Lett. 2021 Aug 18:136182. doi: 10.1016/j.neulet.2021.136182.
    

    >> Share

    
    July 2021
93. SHENG J, Wang L, Cheng H, Zhang Q, et al
    Strategies for multivariate analyses of imaging genetics study in Alzheimer's disease.
    Neurosci Lett. 2021;762:136147.
    

    >> Share

    
    
94. YUE L, Liu P, Ma N, Xu Y, et al
    Interaction between extracellular ATP5A1 and LPS alleviates LPS-induced neuroinflammation in mice.
    Neurosci Lett. 2021;758:136005.
    

    >> Share

    
    
95. AREZOUMANDAN S, Cai X, Kalkarni P, Davis SA, et al
    Hippocampal neurobiology and function in an aged mouse model of TDP-43 proteinopathy in an APP/PSEN1 background.
    Neurosci Lett. 2021;758:136010.
    

    >> Share

    
    
96. SUN B, Yao J, Chen AW, Estillore JP, et al
    Genetically and pharmacologically limiting RyR2 open time prevents neuronal hyperactivity of hippocampal CA1 neurons in brain slices of 5xFAD mice.
    Neurosci Lett. 2021;758:136011.
    

    >> Share

    
    
97. WANDER CM, Song J
    The Neurogenic Niche in Alzheimer's disease.
    Neurosci Lett. 2021 Jul 13:136109. doi: 10.1016/j.neulet.2021.136109.
    

    >> Share

    
    June 2021
98. SINGULANI MP, De Paula VJR, Forlenza OV
    Mitochondrial dysfunction in Alzheimer's disease: therapeutic implications of lithium.
    Neurosci Lett. 2021 Jun 20:136078. doi: 10.1016/j.neulet.2021.136078.
    

    >> Share

    
    
99. HAUSSMANN R, Noppes F, Brandt MD, Bauer M, et al
    Lithium: A therapeutic option in Alzheimer's disease and its prodromal stages?
    Neurosci Lett. 2021 Jun 10:136044. doi: 10.1016/j.neulet.2021.136044.
    

    >> Share

    
    
100. ANDROVICOVA R, Pfaus JG, Ovsepian SV
     Estrogen Pendulum in Schizophrenia and Alzheimer's Disease: Review of Therapeutic Benefits and Outstanding Questions.
     Neurosci Lett. 2021 Jun 8:136038. doi: 10.1016/j.neulet.2021.136038.
     

     >> Share

     
     May 2021
101. DAINI E, Secco V, Liao W, Zoli M, et al
     A regional and cellular analysis of the early intracellular and extracellular accumulation of Abeta in the brain of 5XFAD mice.
     Neurosci Lett. 2021;754:135869.
     

     >> Share

     
     
102. HE B, Wang L, Xu B, Zhang Y, et al
     Association between CSF Abeta42 and amyloid negativity in patients with different stage mild cognitive impairment.
     Neurosci Lett. 2021;754:135765.
     

     >> Share

     
     
103. LAKSHMI S, Raghu SV, Elumalai P, Sivan S, et al
     Alkoxylglycerol enhanced activity of Oxyresveratrol in Alzheimer's disease by rescuing Tau protein.
     Neurosci Lett. 2021 May 20:135981. doi: 10.1016/j.neulet.2021.135981.
     

     >> Share

     
     
104. ZARETSKY DV, Zaretskaia MV
     Mini-review: Amyloid degradation toxicity hypothesis of Alzheimer's disease.
     Neurosci Lett. 2021;756:135959.
     

     >> Share

     
     
105. ZHANG H, Ge H, Li K
     Aberrant expression of miR-148a-3p in Alzheimer's disease and its protective role against amyloid-beta induced neurotoxicity.
     Neurosci Lett. 2021 May 9:135953. doi: 10.1016/j.neulet.2021.135953.
     

     >> Share

     
     
106. SHAMSIPOUR S, Sharifi G, Taghian F
     Impact of interval training with probiotic (L. plantarum / Bifidobacterium bifidum) on passive avoidance test, ChAT and BDNF in the hippocampus of rats with Alzheimer's disease.
     Neurosci Lett. 2021;756:135949.
     

     >> Share

     
     April 2021
107. ARIOZ BI, Tufekci KU, Olcum M, Durur DY, et al
     Proteome profiling of neuron-derived exosomes in Alzheimer's disease reveals hemoglobin as a potential biomarker.
     Neurosci Lett. 2021;755:135914.
     

     >> Share

     
     
108. OVSEPIAN SV, O'Leary VB, Hoschl C, Zaborszky L, et al
     Integrated Phylogeny of the Human Brain and Pathobiology of Alzheimer's Disease: A Unifying Hypothesis.
     Neurosci Lett. 2021 Apr 13:135895. doi: 10.1016/j.neulet.2021.135895.
     

     >> Share

     
     
109. GKANATSIOU E, Sahlin C, Portelius E, Johannesson M, et al
     Characterization of monomeric and soluble aggregated Abeta in Down's syndrome and Alzheimer's disease brains.
     Neurosci Lett. 2021 Apr 10:135894. doi: 10.1016/j.neulet.2021.135894.
     

     >> Share

     
     
110. RASHTIANI S, Goudarzi I, Jafari A, Rohampour K, et al
     Adenosine monophosphate activated protein kinase (AMPK) is essential for the memory improving effect of adiponectin.
     Neurosci Lett. 2021;749:135721.
     

     >> Share

     
     February 2021
111. SANTOS-GIL DF, Arboleda G, Sandoval-Hernandez AG
     Retinoid X Receptor activation promotes re-myelination in a very old triple transgenic mouse model of Alzheimer's disease.
     Neurosci Lett. 2021 Feb 20:135764. doi: 10.1016/j.neulet.2021.135764.
     

     >> Share

     
     
112. GIL L, Nino SA, Capdeville G, Jimenez-Capdeville ME, et al
     AGING AND ALZHEIMER S DISEASE CONNECTION: NUCLEAR TAU AND LAMIN A.
     Neurosci Lett. 2021 Feb 18:135741. doi: 10.1016/j.neulet.2021.135741.
     

     >> Share

     
     
113. JOHNSON MD
     Evaluation of fluid channels in the human dura and superior sagittal sinus in older patients.
     Neurosci Lett. 2021;746:135649.
     

     >> Share

     
     
114. LIM KH, Kim SH, Yang S, Chun S, et al
     Advances in multiplex PCR for Alzheimer's disease diagnostics targeting CDK genes.
     Neurosci Lett. 2021 Feb 15:135715. doi: 10.1016/j.neulet.2021.135715.
     

     >> Share

     
     
115. XU L, Dong Q, Xu L, Zou W, et al
     The MCP-1 A-2518G polymorphism increases the risk of Alzheimer's disease: a case-control study.
     Neurosci Lett. 2021 Feb 9:135710. doi: 10.1016/j.neulet.2021.135710.
     

     >> Share

     
     January 2021
116. LIANG C, Mu Y, Tian H, Wang D, et al
     MicroRNA-140 silencing represses the incidence of Alzheimer's disease.
     Neurosci Lett. 2021 Jan 30:135674. doi: 10.1016/j.neulet.2021.135674.
     

     >> Share

     
     
117. ZHANG B, Wu L, Zhu Q, Dong Y, et al
     Donepezil attenuates the development of morphine tolerance in rats with cancer-induced bone pain: the role of cortical N-methyl-D-aspartate receptors.
     Neurosci Lett. 2021 Jan 28:135678. doi: 10.1016/j.neulet.2021.135678.
     

     >> Share

     
     
118. WANG Y, Sheng H, Zhao J, Guo L, et al
     Changes in the prefrontal cortex after the hippocampus was injected with Abeta25-35 via the P35/P25-CDK5-Tau hyperphosphorylation signaling pathway.
     Neurosci Lett. 2021;741:135453.
     

     >> Share

     
     
119. DIXIT MP, Rahmatkar SN, Raut P, Umekar MJ, et al
     Evidences for agmatine alterations in Abeta1-42induced memory impairment in mice.
     Neurosci Lett. 2021;740:135447.
     

     >> Share

     
     December 2020
120. WANG J, Guo MN, Liu ZZ, Ma SF, et al
     PGC-1alpha reduces Amyloid-beta deposition in Alzheimer's disease: Effect of increased VDR expression.
     Neurosci Lett. 2020;744:135598.
     

     >> Share

     
     
121. TIAN Z, Dong Q, Wu T, Guo J, et al
     MicroRNA-20b-5p aggravates neuronal apoptosis induced by beta-Amyloid via down-regulation of Ras homolog family member C in Alzheimer's disease.
     Neurosci Lett. 2020 Dec 2:135542. doi: 10.1016/j.neulet.2020.135542.
     

     >> Share

     
     November 2020
122. SONG X, Chen J, Hou Z, Xie N, et al
     Antimicrobial therapy and the potential mechanisms in Alzheimer's disease.
     Neurosci Lett. 2020 Nov 6:135464. doi: 10.1016/j.neulet.2020.135464.
     

     >> Share

     
     May 2020
123. LIU HJ, Li XY, Chen H, Yu HL, et al
     Identification of susceptibility loci for cognitive impairment in a cohort of Han Chinese patients with Parkinson's disease.
     Neurosci Lett. 2020 May 10:135034. doi: 10.1016/j.neulet.2020.135034.
     

     >> Share

     
     April 2020
124. ACERO G, Garay C, Venegas D, Ortega E, et al
     Novel monoclonal antibody 3B8 specifically recognizes pyroglutamate-modified amyloid beta 3-42 peptide in brain of AD patients and 3xTg-AD transgenic mice.
     Neurosci Lett. 2020;724:134876.
     

     >> Share

     
     February 2020
125. ZHANG Z, Gao W, Wang X, Zhang D, et al
     Geniposide effectively reverses cognitive impairment and inhibits pathological cerebral damage by regulating the mTOR Signal pathway in APPPS1 mice.
     Neurosci Lett. 2020;720:134749.
     

     >> Share

     
     

Free Medical Abstracts
Privacy Policy
Sponsors
Share